How can clinicians enhance drug adherence in early-stage breast cancer?

17 Просмотры

  • Спасибо! Поделитесь с друзьями!

    Вам не понравилось видео. Спасибо за то что поделились своим мнением!

admin
Издатель
Matteo Lambertini, MD, PhD, IRCCS Ospedale Policlinico San Martino, Genova, Italy, discusses the importance of adherence to adjuvant endocrine therapy in patients with breast cancer, highlighting the negative impact of endocrine therapy on quality of life and its potential influence on treatment adherence. Proactive management of side effects is essential, which can be achieved through various pharmacological and non-pharmacological strategies, such as physical exercise, acupuncture, and cognitive behavioral therapy. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Категория
Рак Молочной Железы
Комментариев нет.

Следующее